newsfilter
← Latest News
GlobeNewswire·

Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference

  • Cue Biopharma, Inc. (NASDAQ: CUE) announced that CEO Shao-Lee Lin will present at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 3:10 p.m. EDT in New York City.
  • A live audio webcast & replay of the presentation will be available on the company's Investor Relations website & archived for 90 days.
  • The company's lead asset is a novel anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases.
  • Cue's Immuno-STAT® platform selectively targets disease-specific T cells in vivo without broad immune modulation.
  • The lead autoimmune candidate, CUE-401, is advancing towards Phase 1 to regulate inflammation & drive Treg-mediated tolerance.
  • Investor & media contact information is available for Agnes Lee, Chief Officer of Public and Investor Relations, & Marie Campinell, Senior Director of Corporate Communications.